Tetracycline-class Drug [EPC]

Tetracycline-class Drug [EPC] was reported 70772 times

Drugs of the Tetracycline-class Drug [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 AMYLOID ARTHROPATHY 61 0.8714
1 GRIP STRENGTH 143 0.6245
2 CONGENITAL HIATUS HERNIA 118 0.5175
3 C-REACTIVE PROTEIN 470 0.5070
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 300 0.4491
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 898 0.4483
6 SWOLLEN JOINT COUNT 112 0.4480
7 JARISCH-HERXHEIMER REACTION 314 0.4410
8 LUPUS VULGARIS 532 0.4222
9 GASTROINTESTINAL MUCOSAL NECROSIS 55 0.3793
10 SWOLLEN JOINT COUNT INCREASED 1044 0.3271
11 ABORTION INCOMPLETE 553 0.2968
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 535 0.2580
13 RHEUMATIC FEVER 1134 0.2541
14 RETINITIS 428 0.2475
15 FACET JOINT SYNDROME 745 0.2286
16 DISLOCATION OF VERTEBRA 486 0.2129
17 X-RAY ABNORMAL 380 0.2123
18 RHEUMATOID FACTOR POSITIVE 1216 0.2103
19 OVERLAP SYNDROME 126 0.1800
20 DUODENAL ULCER PERFORATION 1277 0.1715
21 SERONEGATIVE ARTHRITIS 177 0.1545
22 BONE EROSION 522 0.1475
23 C-REACTIVE PROTEIN ABNORMAL 946 0.1473
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 913 0.1404
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 953 0.1329
26 HELICOBACTER INFECTION 1332 0.1295
27 PORPHYRIA ACUTE 179 0.1247
28 FOLLICULITIS 1243 0.1184
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 120 0.1130
30 MUSCLE INJURY 911 0.1098
31 PERIPHERAL VENOUS DISEASE 418 0.1023
32 HAND DEFORMITY 1318 0.1004
33 AUTOIMMUNE DISORDER 923 0.0946
34 DRUG TOLERANCE DECREASED 257 0.0914
35 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 51 0.0909
36 LIP DRY 822 0.0904
37 HYPERPARATHYROIDISM SECONDARY 226 0.0901
38 NEPHROGENIC ANAEMIA 409 0.0882
39 REBOUND ACID HYPERSECRETION 265 0.0875
40 GRANULOMA SKIN 71 0.0865
41 PEMPHIGUS 1047 0.0837
42 FIXED ERUPTION 144 0.0836
43 ENDOMETRITIS 55 0.0827
44 BREAST CANCER STAGE III 497 0.0767
45 HYPERCHOLESTEROLAEMIA 725 0.0750
46 SYNOVITIS 1344 0.0745
47 JOINT RANGE OF MOTION DECREASED 968 0.0721
48 SCIATICA 1128 0.0707
49 MALIGNANT MELANOMA IN SITU 87 0.0702
50 GRIP STRENGTH DECREASED 578 0.0656
51 PERICARDITIS 1083 0.0644
52 WOUND INFECTION 698 0.0637
53 GLOSSODYNIA 1396 0.0623
54 CHOLANGITIS SCLEROSING 126 0.0613
55 EXOSTOSIS 543 0.0594
56 IRRITABLE BOWEL SYNDROME 1223 0.0570
57 FIBROMYALGIA 1371 0.0563
58 BURSITIS 653 0.0538
59 LYME DISEASE 178 0.0533
60 LUPUS-LIKE SYNDROME 482 0.0531
61 LIVE BIRTH 440 0.0525
62 BREATH SOUNDS ABNORMAL 256 0.0519
63 RED BLOOD CELL SEDIMENTATION RATE INCREASED 562 0.0507
64 WOUND 1405 0.0502
65 WALKING AID USER 322 0.0488
66 PELVIC INFLAMMATORY DISEASE 72 0.0482
67 LOWER LIMB FRACTURE 917 0.0477
68 ASPERGILLUS INFECTION 311 0.0473
69 BLOOD PARATHYROID HORMONE DECREASED 70 0.0472
70 OESOPHAGEAL ULCER 180 0.0468
71 MATERNAL EXPOSURE TIMING UNSPECIFIED 175 0.0465
72 JOINT DISLOCATION 477 0.0451
73 END STAGE RENAL DISEASE 807 0.0442
74 GASTROINTESTINAL INJURY 118 0.0438
75 LIVER INJURY 1059 0.0431
76 FOOT DEFORMITY 474 0.0427
77 BRONCHIAL HYPERREACTIVITY 51 0.0424
78 IMPAIRED HEALING 1365 0.0415
79 HIDRADENITIS 375 0.0411
80 TYPE 2 DIABETES MELLITUS 1362 0.0404
81 ROSACEA 188 0.0403
82 SYSTEMIC LUPUS ERYTHEMATOSUS 1371 0.0386
83 OBESITY 615 0.0386
84 PULMONARY FIBROSIS 697 0.0363
85 PRESCRIBED OVERDOSE 702 0.0362
86 CHRONIC KIDNEY DISEASE 2684 0.0353
87 PULMONARY FUNCTION TEST ABNORMAL 55 0.0353
88 PANNICULITIS 79 0.0326
89 HIP ARTHROPLASTY 498 0.0325
90 CONTRAINDICATED PRODUCT ADMINISTERED 974 0.0321
91 PSORIATIC ARTHROPATHY 1300 0.0320
92 METHAEMOGLOBINAEMIA 74 0.0319
93 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 78 0.0315
94 INFUSION SITE DISCHARGE 55 0.0313
95 PRESCRIBED UNDERDOSE 618 0.0309
96 CHOLESTATIC LIVER INJURY 68 0.0305
97 WHEEZING 1807 0.0304
98 HEPATIC CIRRHOSIS 571 0.0304
99 SPONDYLITIS 110 0.0302
100 BENIGN PROSTATIC HYPERPLASIA 154 0.0298
101 DERMATITIS ACNEIFORM 181 0.0297
102 PULMONARY PAIN 86 0.0294
103 ONYCHOMADESIS 121 0.0288
104 OESOPHAGITIS 314 0.0287
105 RHEUMATOID NODULE 79 0.0287
106 LOWER RESPIRATORY TRACT INFECTION 1300 0.0286
107 BRONCHIECTASIS 190 0.0282
108 ROAD TRAFFIC ACCIDENT 1147 0.0274
109 PHOTOSENSITIVITY REACTION 452 0.0273
110 PREGNANCY 545 0.0272
111 IDIOPATHIC INTRACRANIAL HYPERTENSION 61 0.0271
112 BLISTER 1520 0.0270
113 OSTEOARTHRITIS 1123 0.0265
114 GAIT INABILITY 881 0.0263
115 CYTOPENIA 320 0.0261
116 INTRACRANIAL PRESSURE INCREASED 142 0.0255
117 BLOOD CHOLESTEROL INCREASED 1170 0.0251
118 PUSTULE 59 0.0249
119 SPINAL FUSION SURGERY 100 0.0246
120 KNEE ARTHROPLASTY 517 0.0245
121 EAR INFECTION 653 0.0245
122 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 406 0.0239
123 ARTHROPATHY 1310 0.0235
124 INFUSION SITE REACTION 70 0.0234
125 INJURY 1636 0.0233
126 INFUSION RELATED REACTION 1536 0.0232
127 HEPATIC ENZYME INCREASED 1579 0.0231
128 NIGHT SWEATS 741 0.0230
129 TUBULOINTERSTITIAL NEPHRITIS 424 0.0226
130 ULCER HAEMORRHAGE 153 0.0226
131 LUNG CONSOLIDATION 63 0.0225
132 LIVER DISORDER 991 0.0223
133 STOMATITIS 1343 0.0221
134 OEDEMA 1189 0.0219
135 TACHYARRHYTHMIA 54 0.0216
136 ISCHAEMIC CARDIOMYOPATHY 65 0.0212
137 JOINT STIFFNESS 555 0.0211
138 SINUSITIS 2168 0.0211
139 EYE INJURY 64 0.0210
140 MOBILITY DECREASED 1513 0.0210
141 BLEPHAROSPASM 132 0.0209
142 PEMPHIGOID 157 0.0208
143 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 111 0.0204
144 DRUG TOLERANCE 103 0.0203
145 INFLAMMATION 1039 0.0201
146 DISCOMFORT 1216 0.0199
147 PARONYCHIA 87 0.0198
148 BREAST CANCER STAGE II 162 0.0195
149 ECONOMIC PROBLEM 294 0.0194
150 TREATMENT FAILURE 1583 0.0191
151 OSTEOPOROSIS 782 0.0190
152 C-REACTIVE PROTEIN INCREASED 683 0.0188
153 DELIRIUM 650 0.0187
154 EAR PAIN 364 0.0187
155 INFUSION SITE PRURITUS 58 0.0184
156 LUNG DISORDER 897 0.0183
157 THERAPEUTIC PRODUCT EFFECT DECREASED 811 0.0181
158 DRUG-INDUCED LIVER INJURY 567 0.0181
159 THERAPY NON-RESPONDER 810 0.0180
160 ULCERATIVE KERATITIS 49 0.0179
161 ABSCESS LIMB 76 0.0178
162 NAIL DISORDER 156 0.0178
163 DRUG INTOLERANCE 1690 0.0175
164 SWELLING 1603 0.0171
165 SUBCUTANEOUS ABSCESS 82 0.0171
166 ODYNOPHAGIA 102 0.0171
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 819 0.0170
168 INFECTION 2456 0.0170
169 PAPILLOEDEMA 76 0.0168
170 OBSTRUCTIVE AIRWAYS DISORDER 187 0.0168
171 OESOPHAGEAL PAIN 66 0.0167
172 MUSCULOSKELETAL STIFFNESS 1459 0.0166
173 FULL BLOOD COUNT ABNORMAL 176 0.0166
174 ANHEDONIA 437 0.0166
175 PUSTULAR PSORIASIS 57 0.0166
176 UPPER RESPIRATORY TRACT INFECTION 752 0.0163
177 SLEEP DISORDER 1146 0.0162
178 RHEUMATOID ARTHRITIS 1837 0.0162
179 JOINT SWELLING 1952 0.0162
180 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 277 0.0161
181 MUSCULOSKELETAL PAIN 838 0.0160
182 ARTHRITIS INFECTIVE 74 0.0159
183 TENDERNESS 166 0.0159
184 RASH VESICULAR 77 0.0159
185 ILL-DEFINED DISORDER 967 0.0159
186 ACUTE KIDNEY INJURY 2424 0.0158
187 SUNBURN 118 0.0158
188 MOUTH SWELLING 91 0.0158
189 SUSPECTED OFF LABEL USE 71 0.0157
190 HYPERTRANSAMINASAEMIA 109 0.0157
191 INFUSION SITE HAEMORRHAGE 51 0.0155
192 GASTROINTESTINAL DISORDER 1386 0.0155
193 ASTHMA 1732 0.0153
194 WEIGHT FLUCTUATION 160 0.0153
195 RENAL INJURY 453 0.0152
196 SKIN NECROSIS 79 0.0152
197 ARTHROPOD BITE 112 0.0151
198 RENAL TUBULAR NECROSIS 148 0.0151
199 DRY MOUTH 1224 0.0151
200 CUSHINGOID 48 0.0149
201 SKIN INFECTION 166 0.0148
202 MICTURITION URGENCY 168 0.0147
203 CHRONIC SINUSITIS 55 0.0146
204 LIVER FUNCTION TEST INCREASED 312 0.0145
205 PARANASAL SINUS DISCOMFORT 55 0.0145
206 DISABILITY 287 0.0145
207 CONTUSION 1393 0.0145
208 POLYARTHRITIS 76 0.0144
209 INFLAMMATORY MARKER INCREASED 71 0.0143
210 CYSTIC FIBROSIS 79 0.0143
211 SEASONAL ALLERGY 201 0.0142
212 CHOLECYSTITIS CHRONIC 95 0.0142
213 INFUSION SITE SWELLING 89 0.0141
214 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 109 0.0140
215 RENAL FAILURE 1850 0.0139
216 SPUTUM DISCOLOURED 132 0.0139
217 PAPULE 98 0.0139
218 ONYCHOMYCOSIS 61 0.0139
219 INTENTIONAL PRODUCT USE ISSUE 1215 0.0139
220 HORDEOLUM 60 0.0139
221 ORAL CANDIDIASIS 182 0.0138
222 NORMAL NEWBORN 75 0.0138
223 WOUND SECRETION 54 0.0138
224 GASTROOESOPHAGEAL REFLUX DISEASE 1109 0.0138
225 BRONCHITIS 1019 0.0138
226 PANCREATITIS ACUTE 309 0.0137
227 GENERAL PHYSICAL HEALTH DETERIORATION 1582 0.0137
228 HYPOAESTHESIA 2040 0.0136
229 GASTRITIS EROSIVE 63 0.0135
230 MELANOCYTIC NAEVUS 59 0.0134
231 AUTOIMMUNE HEPATITIS 92 0.0132
232 ABDOMINAL DISCOMFORT 2210 0.0132
233 DERMATITIS BULLOUS 94 0.0130
234 TENDON PAIN 98 0.0129
235 PRE-EXISTING CONDITION IMPROVED 80 0.0128
236 DRUG RESISTANCE 329 0.0128
237 HYPERVOLAEMIA 63 0.0127
238 MATERNAL EXPOSURE DURING PREGNANCY 1119 0.0125
239 RASH PUSTULAR 91 0.0125
240 OSTEOPENIA 189 0.0124
241 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 681 0.0124
242 RALES 72 0.0124
243 MULTIPLE ALLERGIES 97 0.0124
244 SKIN ULCER 317 0.0123
245 HYPERSENSITIVITY 2274 0.0122
246 PRODUCT ADMINISTRATION INTERRUPTED 96 0.0122
247 CARDIOMEGALY 149 0.0121
248 AMNESIA 788 0.0121
249 TOXIC EPIDERMAL NECROLYSIS 183 0.0120
250 LIP SWELLING 400 0.0120
251 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 854 0.0120
252 PRODUCTIVE COUGH 572 0.0120
253 RESPIRATORY DISORDER 358 0.0120
254 PHOTOPHOBIA 223 0.0118
255 PERIPHERAL SWELLING 1821 0.0118
256 UTERINE PERFORATION 100 0.0118
257 FOREIGN BODY SENSATION IN EYES 75 0.0118
258 ARTHRITIS 920 0.0117
259 VAGINAL INFECTION 55 0.0117
260 PERIORBITAL SWELLING 66 0.0117
261 HALLUCINATIONS, MIXED 49 0.0116
262 ULCER 185 0.0116
263 SPINAL OSTEOARTHRITIS 102 0.0116
264 FURUNCLE 92 0.0116
265 CYST 144 0.0116
266 BASAL CELL CARCINOMA 180 0.0115
267 HAEMORRHAGE 1205 0.0115
268 PATHOGEN RESISTANCE 105 0.0115
269 INFUSION SITE ERYTHEMA 97 0.0115
270 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 296 0.0115
271 DYSPEPSIA 1131 0.0115
272 ATELECTASIS 111 0.0115
273 RHINITIS ALLERGIC 51 0.0114
274 URTICARIA 1913 0.0114
275 CELLULITIS 572 0.0113
276 VASCULAR DEVICE INFECTION 51 0.0112
277 SKIN MASS 75 0.0112
278 RENAL CYST 89 0.0112
279 NEPHROPATHY 104 0.0111
280 STAPHYLOCOCCAL INFECTION 366 0.0111
281 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 577 0.0110
282 SKIN ABRASION 52 0.0110
283 DERMATITIS 229 0.0109
284 SKIN LESION 299 0.0109
285 CANDIDA INFECTION 184 0.0109
286 INFUSION SITE PAIN 140 0.0109
287 LYMPHOEDEMA 75 0.0108
288 DRUG ERUPTION 192 0.0108
289 MYOSITIS 97 0.0108
290 STEVENS-JOHNSON SYNDROME 239 0.0107
291 RESPIRATORY TRACT INFECTION 280 0.0107
292 PSEUDOMONAS INFECTION 92 0.0107
293 HYPERTENSION 2269 0.0107
294 SWELLING OF EYELID 67 0.0107
295 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 80 0.0106
296 CLOSTRIDIUM DIFFICILE COLITIS 113 0.0106
297 FACIAL PAIN 95 0.0106
298 DERMATITIS CONTACT 121 0.0106
299 CONFUSIONAL STATE 1695 0.0105
300 SKIN WARM 61 0.0105
301 INTERVERTEBRAL DISC DEGENERATION 97 0.0105
302 LOCALISED OEDEMA 48 0.0104
303 CHEST PAIN 1910 0.0103
304 SCAR 176 0.0103
305 SKIN HYPERPIGMENTATION 88 0.0102
306 CONDITION AGGRAVATED 3109 0.0102
307 EYE PAIN 576 0.0102
308 HYPOMAGNESAEMIA 142 0.0102
309 SKIN PLAQUE 86 0.0102
310 NODULE 133 0.0102
311 SWOLLEN TONGUE 318 0.0102
312 TASTE DISORDER 206 0.0101
313 LOCALISED INFECTION 243 0.0100
314 RASH PRURITIC 544 0.0100
315 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 50 0.0100
316 FREQUENT BOWEL MOVEMENTS 270 0.0100
317 CHEILITIS 54 0.0100
318 RASH 4350 0.0100
319 UPPER-AIRWAY COUGH SYNDROME 82 0.0099
320 COLITIS ULCERATIVE 440 0.0098
321 OEDEMA PERIPHERAL 1195 0.0098
322 OSTEOMYELITIS 177 0.0098
323 POST PROCEDURAL INFECTION 79 0.0097
324 PERIPHERAL VASCULAR DISORDER 50 0.0097
325 NASOPHARYNGITIS 1784 0.0097
326 APPETITE DISORDER 64 0.0096
327 SINUS CONGESTION 130 0.0096
328 DYSPNOEA EXERTIONAL 360 0.0095
329 HAEMOPTYSIS 266 0.0095
330 ACUTE RESPIRATORY FAILURE 181 0.0094
331 ANXIETY 2674 0.0094
332 RASH MACULO-PAPULAR 209 0.0094
333 MUSCULOSKELETAL CHEST PAIN 145 0.0094
334 EOSINOPHILIA 164 0.0093
335 TOOTH ABSCESS 95 0.0093
336 CLOSTRIDIUM DIFFICILE INFECTION 203 0.0093
337 BLOOD MAGNESIUM DECREASED 80 0.0093
338 HERPES SIMPLEX 60 0.0092
339 VITAMIN D DEFICIENCY 90 0.0092
340 TENDON DISORDER 60 0.0092
341 THERAPY PARTIAL RESPONDER 143 0.0092
342 MIGRAINE 874 0.0091
343 HEPATITIS 234 0.0091
344 MULTIPLE ORGAN DYSFUNCTION SYNDROME 259 0.0091
345 WHITE BLOOD CELL COUNT INCREASED 349 0.0091
346 ALOPECIA 1779 0.0090
347 TENDONITIS 140 0.0090
348 EYE INFECTION 102 0.0090
349 MAJOR DEPRESSION 66 0.0090
350 DECREASED APPETITE 2096 0.0090
351 BACK INJURY 98 0.0090
352 PANCREATITIS 476 0.0090
353 JOINT INJURY 192 0.0090
354 MEDICATION ERROR 497 0.0089
355 CONGENITAL ANOMALY 69 0.0089
356 TINNITUS 408 0.0089
357 MENORRHAGIA 174 0.0089
358 VASCULITIS 103 0.0088
359 PNEUMONIA BACTERIAL 81 0.0088
360 RECTAL HAEMORRHAGE 379 0.0088
361 EXPOSURE DURING PREGNANCY 548 0.0088
362 ABDOMINAL PAIN UPPER 1812 0.0088
363 PULMONARY MASS 131 0.0088
364 GASTRIC ULCER 166 0.0087
365 PNEUMONIA 2804 0.0087
366 HYPERCALCAEMIA 106 0.0086
367 ATRIAL FIBRILLATION 835 0.0086
368 RIB FRACTURE 176 0.0085
369 NEUTROPENIC SEPSIS 61 0.0085
370 SLEEP APNOEA SYNDROME 163 0.0085
371 VOMITING 4013 0.0085
372 CONJUNCTIVITIS 158 0.0085
373 ECCHYMOSIS 58 0.0085
374 MUSCULAR WEAKNESS 959 0.0084
375 SWELLING FACE 549 0.0084
376 JOINT EFFUSION 58 0.0084
377 HYPERAESTHESIA 69 0.0084
378 LABORATORY TEST ABNORMAL 247 0.0084
379 INFUSION SITE EXTRAVASATION 52 0.0083
380 MUSCLE STRAIN 72 0.0083
381 HYPERLIPIDAEMIA 99 0.0083
382 CHOLESTASIS 159 0.0083
383 QUALITY OF LIFE DECREASED 111 0.0083
384 SINUS HEADACHE 49 0.0082
385 HEPATIC CYTOLYSIS 105 0.0082
386 DENTAL CARIES 91 0.0082
387 PYREXIA 2836 0.0082
388 VISUAL IMPAIRMENT 1015 0.0082
389 DIVERTICULUM 58 0.0082
390 SCAB 93 0.0081
391 PELVIC PAIN 148 0.0081
392 ONYCHOCLASIS 56 0.0081
393 ORAL PAIN 182 0.0081
394 TOOTH INFECTION 107 0.0081
395 SQUAMOUS CELL CARCINOMA OF SKIN 49 0.0081
396 ARTERIOSCLEROSIS 76 0.0081
397 PHARYNGEAL SWELLING 79 0.0081
398 LEUKOCYTOSIS 146 0.0081
399 SINUS DISORDER 159 0.0080
400 DIARRHOEA HAEMORRHAGIC 75 0.0080
401 PRURITUS 3079 0.0080
402 EYE DISCHARGE 83 0.0080
403 GASTRITIS 210 0.0080
404 MOUTH ULCERATION 168 0.0080
405 INFLAMMATORY BOWEL DISEASE 78 0.0080
406 NECK PAIN 442 0.0079
407 THROMBOCYTOPENIA 884 0.0079
408 EYE SWELLING 294 0.0079
409 PANIC REACTION 57 0.0079
410 DEPRESSION 1790 0.0079
411 OCULAR DISCOMFORT 88 0.0078
412 PRODUCT USE IN UNAPPROVED INDICATION 1939 0.0078
413 SUPRAVENTRICULAR TACHYCARDIA 74 0.0077
414 ABDOMINAL PAIN 1796 0.0077
415 HEPATIC ENCEPHALOPATHY 72 0.0077
416 WEIGHT INCREASED 1725 0.0077
417 REBOUND EFFECT 87 0.0077
418 COELIAC DISEASE 75 0.0076
419 MEMORY IMPAIRMENT 1050 0.0076
420 CARPAL TUNNEL SYNDROME 107 0.0076
421 MULTIPLE INJURIES 48 0.0076
422 POST-TRAUMATIC STRESS DISORDER 51 0.0076
423 SKIN REACTION 107 0.0076
424 FUNGAL INFECTION 253 0.0076
425 ABSCESS 121 0.0076
426 ADVERSE DRUG REACTION 681 0.0076
427 SKIN DISORDER 252 0.0075
428 VITREOUS FLOATERS 74 0.0075
429 SKIN FISSURES 147 0.0075
430 GROIN PAIN 66 0.0075
431 FLANK PAIN 70 0.0075
432 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 66 0.0075
433 LEFT VENTRICULAR DYSFUNCTION 50 0.0075
434 DYSPNOEA 4224 0.0075
435 RHINITIS 60 0.0074
436 RESPIRATORY TRACT CONGESTION 118 0.0074
437 POSTOPERATIVE WOUND INFECTION 50 0.0074
438 JAUNDICE 199 0.0074
439 EPILEPSY 226 0.0074
440 AORTIC ANEURYSM 56 0.0074
441 PULMONARY THROMBOSIS 80 0.0073
442 ADRENAL INSUFFICIENCY 89 0.0073
443 BACK DISORDER 119 0.0073
444 CARDIOMYOPATHY 108 0.0073
445 INCREASED TENDENCY TO BRUISE 67 0.0073
446 LIGAMENT SPRAIN 72 0.0073
447 PARAESTHESIA 1144 0.0073
448 RASH MACULAR 254 0.0073
449 PHARYNGITIS 90 0.0072
450 MUSCLE SPASMS 1330 0.0072
451 LUNG INFILTRATION 64 0.0072
452 ARTERIOSCLEROSIS CORONARY ARTERY 48 0.0072
453 INSOMNIA 1925 0.0072
454 SQUAMOUS CELL CARCINOMA 68 0.0072
455 OROPHARYNGEAL PAIN 667 0.0072
456 MALAISE 3155 0.0072
457 CORONARY ARTERY DISEASE 216 0.0071
458 DEAFNESS 185 0.0071
459 ARTHRALGIA 2941 0.0071
460 INTERNATIONAL NORMALISED RATIO INCREASED 201 0.0070
461 IMMUNODEFICIENCY 105 0.0070
462 IRON DEFICIENCY ANAEMIA 65 0.0070
463 BRAIN FOG 110 0.0070
464 UPPER GASTROINTESTINAL HAEMORRHAGE 118 0.0070
465 INSURANCE ISSUE 107 0.0070
466 FOOD ALLERGY 54 0.0070
467 BACTERAEMIA 83 0.0070
468 DYSURIA 257 0.0070
469 GASTROENTERITIS VIRAL 126 0.0070
470 TACHYCARDIA 619 0.0070
471 RESPIRATION ABNORMAL 48 0.0070
472 DUODENAL ULCER 49 0.0069
473 COVID-19 PNEUMONIA 82 0.0069
474 HICCUPS 57 0.0069
475 PROTEINURIA 132 0.0069
476 EAR DISCOMFORT 71 0.0069
477 GASTROINTESTINAL INFECTION 62 0.0069
478 GINGIVAL PAIN 55 0.0069
479 TRANSIENT ISCHAEMIC ATTACK 233 0.0069
480 HYPOXIA 243 0.0069
481 PURPURA 61 0.0069
482 HYPOKALAEMIA 318 0.0069
483 ANAEMIA 1314 0.0069
484 RENAL PAIN 73 0.0069
485 MASS 96 0.0069
486 FEELING HOT 421 0.0069
487 DERMATITIS ALLERGIC 86 0.0068
488 APHTHOUS ULCER 53 0.0068
489 RHINORRHOEA 440 0.0068
490 SKIN LACERATION 74 0.0068
491 FEBRILE NEUTROPENIA 451 0.0068
492 PULMONARY TOXICITY 48 0.0068
493 HAND FRACTURE 48 0.0068
494 SPINAL COMPRESSION FRACTURE 56 0.0068
495 PAIN 4160 0.0068
496 RASH ERYTHEMATOUS 323 0.0067
497 BONE DISORDER 123 0.0067
498 GAIT DISTURBANCE 1289 0.0067
499 PNEUMOCYSTIS JIROVECII PNEUMONIA 67 0.0067
500 SMALL INTESTINAL OBSTRUCTION 82 0.0067
501 NAUSEA 5252 0.0066
502 DRY EYE 331 0.0066
503 DEEP VEIN THROMBOSIS 430 0.0066
504 BACTERIAL INFECTION 123 0.0066
505 MYOCARDIAL ISCHAEMIA 75 0.0066
506 DIARRHOEA 4246 0.0066
507 HEADACHE 4120 0.0066
508 ESCHERICHIA INFECTION 54 0.0066
509 DIVERTICULITIS 181 0.0065
510 LIPASE INCREASED 50 0.0065
511 NEUROPATHY PERIPHERAL 620 0.0065
512 SKIN EXFOLIATION 549 0.0065
513 BLOOD PRESSURE DIASTOLIC DECREASED 48 0.0065
514 DRUG INTERACTION 1031 0.0065
515 EYE INFLAMMATION 62 0.0065
516 INTERVERTEBRAL DISC PROTRUSION 142 0.0065
517 HEAD DISCOMFORT 115 0.0065
518 HIATUS HERNIA 84 0.0065
519 PHARYNGITIS STREPTOCOCCAL 70 0.0065
520 WEIGHT DECREASED 1802 0.0064
521 PARAESTHESIA ORAL 93 0.0064
522 NEPHROLITHIASIS 295 0.0064
523 LIVER FUNCTION TEST ABNORMAL 187 0.0064
524 BLOOD IRON DECREASED 76 0.0064
525 SPLENOMEGALY 75 0.0064
526 DRY THROAT 65 0.0064
527 MUSCULOSKELETAL DISCOMFORT 110 0.0064
528 COUGH 1790 0.0064
529 FOOT FRACTURE 121 0.0064
530 PRODUCT USE ISSUE 1198 0.0064
531 BODY TEMPERATURE INCREASED 130 0.0064
532 HAEMOLYTIC ANAEMIA 57 0.0064
533 PAROSMIA 48 0.0064
534 EOSINOPHIL COUNT INCREASED 53 0.0064
535 CARDIAC MURMUR 55 0.0064
536 BONE DENSITY DECREASED 199 0.0063
537 TOOTH FRACTURE 70 0.0063
538 MALNUTRITION 71 0.0063
539 EMPHYSEMA 64 0.0063
540 FATIGUE 4939 0.0063
541 PAIN IN EXTREMITY 1863 0.0063
542 CHEST DISCOMFORT 647 0.0063
543 THINKING ABNORMAL 117 0.0063
544 ACUTE RESPIRATORY DISTRESS SYNDROME 111 0.0063
545 MITRAL VALVE INCOMPETENCE 71 0.0063
546 RESTLESS LEGS SYNDROME 114 0.0063
547 EMOTIONAL DISTRESS 758 0.0063
548 NOCTURIA 76 0.0063
549 EYE IRRITATION 360 0.0062
550 CHROMATURIA 141 0.0062
551 ACUTE HEPATIC FAILURE 85 0.0062
552 ILLNESS 637 0.0062
553 BLOOD ALBUMIN DECREASED 49 0.0062
554 LYMPHADENOPATHY 218 0.0062
555 ROTATOR CUFF SYNDROME 79 0.0061
556 DIZZINESS 3064 0.0061
557 FISTULA 69 0.0061
558 PLEURAL EFFUSION 372 0.0061
559 OBSESSIVE-COMPULSIVE DISORDER 49 0.0061
560 HAEMORRHOIDS 119 0.0061
561 IMPAIRED GASTRIC EMPTYING 83 0.0061
562 LIMB INJURY 165 0.0061
563 PAIN IN JAW 172 0.0061
564 PULMONARY HYPERTENSION 126 0.0060
565 PHARYNGEAL OEDEMA 93 0.0060
566 PETECHIAE 63 0.0060
567 LACRIMATION INCREASED 182 0.0060
568 KIDNEY INFECTION 118 0.0060
569 ADVERSE EVENT 554 0.0060
570 VIRAL INFECTION 200 0.0060
571 ANAPHYLACTIC REACTION 332 0.0060
572 SKIN HAEMORRHAGE 89 0.0060
573 BLOOD COUNT ABNORMAL 91 0.0060
574 DEPRESSED MOOD 317 0.0060
575 HAEMATEMESIS 152 0.0060
576 PANCYTOPENIA 334 0.0060
577 TOOTHACHE 108 0.0060
578 DYSPHAGIA 566 0.0060
579 DECREASED ACTIVITY 64 0.0059
580 SEPSIS 661 0.0059
581 PULMONARY EMBOLISM 562 0.0059
582 TEMPERATURE INTOLERANCE 61 0.0059
583 PERIPHERAL COLDNESS 81 0.0059
584 DECUBITUS ULCER 48 0.0059
585 BRONCHOSPASM 84 0.0059
586 MUSCLE SPASTICITY 72 0.0059
587 ASTHENIA 2199 0.0058
588 TENDON RUPTURE 72 0.0058
589 ENCEPHALOPATHY 143 0.0058
590 HYPOGLYCAEMIA 282 0.0058
591 SPINAL DISORDER 55 0.0058
592 BLOOD POTASSIUM DECREASED 174 0.0058
593 INCONTINENCE 61 0.0058
594 GALLBLADDER DISORDER 103 0.0058
595 PSORIASIS 753 0.0058
596 PAIN OF SKIN 155 0.0058
597 LIMB DISCOMFORT 178 0.0057
598 ACNE 435 0.0057
599 DIPLOPIA 149 0.0057
600 CHOLELITHIASIS 188 0.0057
601 OCULAR HYPERAEMIA 272 0.0057
602 PNEUMONITIS 156 0.0057
603 IMPAIRED QUALITY OF LIFE 82 0.0057
604 OVARIAN CYST 57 0.0057
605 OFF LABEL USE 4978 0.0057
606 ERYTHEMA 1168 0.0057
607 ELECTROLYTE IMBALANCE 66 0.0057
608 BLOOD SODIUM DECREASED 107 0.0057
609 IMMUNOSUPPRESSION 50 0.0057
610 RASH PAPULAR 127 0.0057
611 RENAL IMPAIRMENT 476 0.0057
612 SNEEZING 127 0.0057
613 DISEASE RECURRENCE 268 0.0056
614 VENTRICULAR TACHYCARDIA 93 0.0056
615 URINARY TRACT INFECTION 959 0.0056
616 PULMONARY CONGESTION 74 0.0056
617 RESPIRATORY FAILURE 409 0.0056
618 THERAPEUTIC RESPONSE DECREASED 340 0.0056
619 WRIST FRACTURE 67 0.0056
620 GOUT 100 0.0056
621 ASPIRATION 61 0.0056
622 DEFORMITY 52 0.0056
623 PNEUMOTHORAX 88 0.0055
624 CHILLS 650 0.0055
625 ORAL HERPES 108 0.0055
626 SKIN SWELLING 48 0.0055
627 ECZEMA 289 0.0055
628 EPISTAXIS 413 0.0055
629 RESPIRATORY SYNCYTIAL VIRUS INFECTION 48 0.0055
630 NEURALGIA 134 0.0055
631 HEPATOMEGALY 54 0.0055
632 ANKLE FRACTURE 85 0.0055
633 HOSPICE CARE 54 0.0055
634 SPINAL PAIN 64 0.0055
635 INITIAL INSOMNIA 56 0.0055
636 CYSTITIS 173 0.0054
637 SUICIDAL IDEATION 496 0.0054
638 HALLUCINATION, VISUAL 114 0.0054
639 NEUTROPENIA 731 0.0054
640 HEPATIC STEATOSIS 100 0.0054
641 URINARY INCONTINENCE 159 0.0054
642 DIZZINESS POSTURAL 52 0.0054
643 BURNING SENSATION 376 0.0054
644 THROAT TIGHTNESS 145 0.0054
645 BLOOD ALKALINE PHOSPHATASE INCREASED 133 0.0054
646 SECRETION DISCHARGE 67 0.0053
647 NASAL CONGESTION 314 0.0053
648 SEPTIC SHOCK 232 0.0053
649 OXYGEN SATURATION DECREASED 299 0.0053
650 BACK PAIN 1236 0.0053
651 SYNCOPE 532 0.0053
652 HYPERBILIRUBINAEMIA 55 0.0053
653 NERVE COMPRESSION 49 0.0053
654 PRESYNCOPE 129 0.0053
655 PANIC ATTACK 193 0.0053
656 MENTAL STATUS CHANGES 147 0.0053
657 GLOMERULAR FILTRATION RATE DECREASED 65 0.0053
658 COVID-19 922 0.0052
659 ORAL DISCOMFORT 73 0.0052
660 LETHARGY 301 0.0052
661 ORTHOSTATIC HYPOTENSION 91 0.0052
662 PRODUCT DISTRIBUTION ISSUE 48 0.0052
663 FLUID RETENTION 263 0.0052
664 HYPOPHAGIA 132 0.0052
665 TOOTH LOSS 107 0.0052
666 RETCHING 110 0.0052
667 APHONIA 72 0.0052
668 HAEMATOCRIT DECREASED 102 0.0051
669 HAIR COLOUR CHANGES 64 0.0051
670 ABDOMINAL PAIN LOWER 130 0.0051
671 HAEMATURIA 176 0.0051
672 NERVE INJURY 57 0.0051
673 MYALGIA 870 0.0051
674 ALANINE AMINOTRANSFERASE INCREASED 314 0.0051
675 COAGULOPATHY 85 0.0051
676 RASH GENERALISED 132 0.0051
677 HYPERSOMNIA 146 0.0051
678 NEUTROPHIL COUNT INCREASED 52 0.0051
679 FAECES DISCOLOURED 110 0.0051
680 SINUS BRADYCARDIA 49 0.0051
681 BLOOD CALCIUM DECREASED 57 0.0051
682 DEVICE RELATED INFECTION 78 0.0051
683 MULTIPLE FRACTURES 83 0.0050
684 FEAR 135 0.0050
685 AGRANULOCYTOSIS 93 0.0050
686 INFLUENZA 556 0.0050
687 DYSPHONIA 291 0.0050
688 OSTEONECROSIS OF JAW 123 0.0050
689 HERPES ZOSTER 284 0.0049
690 HYPONATRAEMIA 278 0.0049
691 FEELING JITTERY 94 0.0049
692 IMMUNE SYSTEM DISORDER 65 0.0049
693 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
694 DEHYDRATION 655 0.0049
695 TRANSAMINASES INCREASED 109 0.0049
696 PARANOIA 84 0.0049
697 ASCITES 143 0.0049
698 TREATMENT NONCOMPLIANCE 265 0.0048
699 PALPITATIONS 566 0.0048
700 POOR VENOUS ACCESS 50 0.0048
701 POOR QUALITY SLEEP 104 0.0048
702 VISION BLURRED 663 0.0048
703 POLLAKIURIA 201 0.0048
704 MUCOSAL INFLAMMATION 126 0.0048
705 PRODUCT PRESCRIBING ISSUE 104 0.0048
706 DISEASE PROGRESSION 563 0.0048
707 CARDIAC FAILURE CONGESTIVE 381 0.0047
708 HEART RATE IRREGULAR 107 0.0047
709 AGEUSIA 118 0.0047
710 ASPARTATE AMINOTRANSFERASE INCREASED 251 0.0047
711 PRODUCT ADMINISTRATION ERROR 94 0.0046
712 SINUS TACHYCARDIA 66 0.0046
713 THROAT IRRITATION 208 0.0046
714 SKIN DISCOLOURATION 213 0.0046
715 TACHYPNOEA 63 0.0046
716 HAEMATOMA 120 0.0046
717 DRY SKIN 614 0.0046
718 PRODUCT DOSE OMISSION IN ERROR 130 0.0046
719 CONSTIPATION 996 0.0046
720 NIGHTMARE 158 0.0046
721 HEPATOTOXICITY 101 0.0045
722 HALLUCINATION 341 0.0045
723 SHOCK 104 0.0045
724 LEUKOPENIA 226 0.0045
725 POLYNEUROPATHY 54 0.0045
726 ANOSMIA 65 0.0045
727 ABDOMINAL DISTENSION 467 0.0045
728 SKIN CANCER 96 0.0045
729 BLOOD PRESSURE FLUCTUATION 107 0.0045
730 NEPHROPATHY TOXIC 50 0.0044
731 PALLOR 121 0.0044
732 HYPOTHYROIDISM 142 0.0044
733 GENERALISED OEDEMA 55 0.0044
734 RED BLOOD CELL COUNT DECREASED 127 0.0044
735 CATARACT 264 0.0044
736 RESPIRATORY DISTRESS 122 0.0044
737 SURGERY 259 0.0044
738 TOOTH DISORDER 98 0.0044
739 EYE PRURITUS 148 0.0044
740 PULMONARY OEDEMA 197 0.0044
741 EYELID OEDEMA 51 0.0044
742 PERICARDIAL EFFUSION 101 0.0044
743 FULL BLOOD COUNT DECREASED 88 0.0044
744 UPPER LIMB FRACTURE 87 0.0044
745 THROMBOSIS 351 0.0044
746 GASTROINTESTINAL PAIN 48 0.0044
747 HEART RATE INCREASED 432 0.0044
748 HYPERTHYROIDISM 63 0.0043
749 POST PROCEDURAL COMPLICATION 83 0.0043
750 EATING DISORDER 92 0.0043
751 BLOOD URINE PRESENT 82 0.0043
752 ABORTION SPONTANEOUS 173 0.0043
753 SARS-COV-2 TEST POSITIVE 57 0.0043
754 BALANCE DISORDER 373 0.0043
755 UNDERDOSE 315 0.0043
756 VERTIGO 263 0.0043
757 LUNG INFECTION 67 0.0043
758 HYPOAESTHESIA ORAL 65 0.0043
759 HYPOTENSION 865 0.0043
760 HAEMATOCHEZIA 237 0.0043
761 SPINAL FRACTURE 86 0.0043
762 INTERNAL HAEMORRHAGE 49 0.0043
763 CHOLECYSTITIS 51 0.0043
764 HYPOCALCAEMIA 81 0.0043
765 TREMOR 710 0.0043
766 FEELING COLD 119 0.0043
767 ANGIOEDEMA 189 0.0043
768 MUSCLE ATROPHY 54 0.0043
769 FLUID OVERLOAD 62 0.0043
770 COLD SWEAT 75 0.0043
771 LYMPHOPENIA 60 0.0042
772 IMPAIRED DRIVING ABILITY 48 0.0042
773 DRUG INEFFECTIVE 5538 0.0042
774 INTERSTITIAL LUNG DISEASE 203 0.0042
775 MELAENA 92 0.0042
776 HEAD INJURY 132 0.0042
777 HIP FRACTURE 133 0.0041
778 MIDDLE INSOMNIA 77 0.0041
779 MUSCLE TWITCHING 95 0.0041
780 ELECTROCARDIOGRAM QT PROLONGED 148 0.0041
781 LYMPHOCYTE COUNT DECREASED 72 0.0041
782 PLATELET COUNT INCREASED 53 0.0041
783 BONE PAIN 238 0.0041
784 BLOOD UREA INCREASED 68 0.0041
785 BONE LOSS 61 0.0041
786 PRODUCT DOSE OMISSION ISSUE 1185 0.0040
787 GINGIVAL BLEEDING 55 0.0040
788 COLITIS 152 0.0040
789 CIRCULATORY COLLAPSE 68 0.0040
790 ACTIVITIES OF DAILY LIVING IMPAIRED 79 0.0040
791 SPINAL OPERATION 49 0.0040
792 BLOOD PRESSURE ABNORMAL 79 0.0040
793 INTENTIONAL DOSE OMISSION 113 0.0040
794 DIABETES MELLITUS 302 0.0040
795 MOOD SWINGS 126 0.0039
796 BONE MARROW FAILURE 80 0.0039
797 SENSORY DISTURBANCE 63 0.0039
798 DYSSTASIA 114 0.0039
799 GLAUCOMA 75 0.0039
800 HAIR TEXTURE ABNORMAL 52 0.0039
801 HEPATOCELLULAR INJURY 55 0.0039
802 DRUG LEVEL INCREASED 64 0.0039
803 RENAL DISORDER 179 0.0038
804 HOT FLUSH 289 0.0038
805 BLOOD CREATININE INCREASED 250 0.0038
806 MUSCLE TIGHTNESS 62 0.0038
807 LOSS OF CONSCIOUSNESS 490 0.0038
808 HYPERKALAEMIA 134 0.0038
809 RENAL FAILURE ACUTE 162 0.0038
810 HAEMOGLOBIN DECREASED 392 0.0038
811 GENITAL HAEMORRHAGE 49 0.0038
812 INTENTIONAL PRODUCT MISUSE 333 0.0038
813 SEROTONIN SYNDROME 73 0.0038
814 HYPERHIDROSIS 489 0.0038
815 MENTAL IMPAIRMENT 92 0.0038
816 BLOOD TRIGLYCERIDES INCREASED 67 0.0038
817 EYE DISORDER 124 0.0038
818 CRYING 137 0.0038
819 BLOOD PRESSURE INCREASED 576 0.0038
820 DISTURBANCE IN ATTENTION 203 0.0038
821 FALL 1252 0.0038
822 PSYCHOTIC DISORDER 111 0.0038
823 PRODUCT USE COMPLAINT 59 0.0037
824 HYPOACUSIS 161 0.0037
825 EJECTION FRACTION DECREASED 58 0.0037
826 PROCEDURAL PAIN 103 0.0037
827 GASTRIC DISORDER 127 0.0037
828 IMPAIRED WORK ABILITY 79 0.0037
829 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 665 0.0037
830 UNEVALUABLE EVENT 279 0.0037
831 FACE OEDEMA 62 0.0037
832 BLINDNESS 149 0.0037
833 THYROID DISORDER 56 0.0036
834 GASTROENTERITIS 53 0.0036
835 DISSEMINATED INTRAVASCULAR COAGULATION 51 0.0036
836 DYSARTHRIA 136 0.0036
837 DERMATITIS ATOPIC 190 0.0036
838 HALLUCINATION, AUDITORY 57 0.0036
839 THIRST 64 0.0036
840 RESTLESSNESS 131 0.0036
841 HERNIA 69 0.0036
842 PRURITUS GENERALISED 77 0.0036
843 HEART RATE DECREASED 124 0.0035
844 ERECTILE DYSFUNCTION 90 0.0035
845 THERAPEUTIC RESPONSE UNEXPECTED 157 0.0035
846 LOCAL SWELLING 61 0.0035
847 SUBDURAL HAEMATOMA 50 0.0035
848 FLATULENCE 198 0.0035
849 MOVEMENT DISORDER 112 0.0035
850 PNEUMONIA ASPIRATION 87 0.0035
851 FEELING ABNORMAL 828 0.0035
852 BLOOD POTASSIUM INCREASED 56 0.0034
853 DYSKINESIA 140 0.0034
854 GASTROINTESTINAL HAEMORRHAGE 286 0.0034
855 ARRHYTHMIA 162 0.0034
856 URINARY RETENTION 114 0.0034
857 BLOOD PRESSURE DECREASED 227 0.0034
858 HOSPITALISATION 523 0.0034
859 FEEDING DISORDER 69 0.0034
860 MOOD ALTERED 92 0.0034
861 SPEECH DISORDER 176 0.0034
862 WHITE BLOOD CELL COUNT DECREASED 364 0.0034
863 FLUSHING 341 0.0034
864 COGNITIVE DISORDER 156 0.0033
865 BLOOD BILIRUBIN INCREASED 90 0.0033
866 HEPATIC FAILURE 100 0.0033
867 NEUROTOXICITY 58 0.0033
868 SKIN BURNING SENSATION 237 0.0033
869 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 96 0.0033
870 METABOLIC ACIDOSIS 104 0.0032
871 DISORIENTATION 128 0.0032
872 MENTAL DISORDER 140 0.0032
873 SKIN IRRITATION 147 0.0032
874 MUSCULOSKELETAL DISORDER 61 0.0032
875 VAGINAL HAEMORRHAGE 138 0.0032
876 CARDIAC FAILURE 255 0.0032
877 PLATELET COUNT DECREASED 337 0.0032
878 NERVOUSNESS 165 0.0032
879 ANGINA PECTORIS 90 0.0031
880 SOMNOLENCE 632 0.0031
881 OSTEONECROSIS 103 0.0031
882 DYSGEUSIA 231 0.0031
883 PLASMA CELL MYELOMA 121 0.0031
884 UNRESPONSIVE TO STIMULI 80 0.0031
885 INTESTINAL OBSTRUCTION 116 0.0031
886 MULTI-ORGAN FAILURE 53 0.0031
887 FRACTURE 58 0.0031
888 LACTIC ACIDOSIS 99 0.0031
889 PRODUCT DOSE OMISSION 199 0.0030
890 METASTASES TO LIVER 53 0.0030
891 AGITATION 221 0.0030
892 IRRITABILITY 179 0.0030
893 INFLUENZA LIKE ILLNESS 245 0.0030
894 EMOTIONAL DISORDER 91 0.0029
895 CARDIAC ARREST 243 0.0029
896 HYPERGLYCAEMIA 107 0.0029
897 INCREASED APPETITE 56 0.0029
898 RHABDOMYOLYSIS 122 0.0029
899 THERAPY INTERRUPTED 209 0.0029
900 ERUCTATION 56 0.0029
901 APHASIA 87 0.0029
902 SUICIDE ATTEMPT 174 0.0029
903 THERAPEUTIC RESPONSE SHORTENED 95 0.0029
904 BRADYCARDIA 150 0.0028
905 DIABETES MELLITUS INADEQUATE CONTROL 50 0.0028
906 CHOKING 55 0.0028
907 CARDIAC DISORDER 263 0.0028
908 ABNORMAL DREAMS 77 0.0028
909 ACUTE MYOCARDIAL INFARCTION 81 0.0027
910 THERAPY CESSATION 140 0.0027
911 CARDIO-RESPIRATORY ARREST 113 0.0027
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 77 0.0027
913 DEVICE DISLOCATION 116 0.0027
914 FEMUR FRACTURE 82 0.0026
915 DYSTONIA 51 0.0026
916 TARDIVE DYSKINESIA 73 0.0026
917 SEIZURE 295 0.0026
918 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 59 0.0025
919 NEUTROPHIL COUNT DECREASED 103 0.0025
920 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56 0.0025
921 CARDIOVASCULAR DISORDER 64 0.0025
922 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
923 TOXICITY TO VARIOUS AGENTS 405 0.0024
924 PRODUCT AVAILABILITY ISSUE 54 0.0024
925 VISUAL ACUITY REDUCED 78 0.0023
926 CEREBRAL INFARCTION 57 0.0023
927 NERVOUS SYSTEM DISORDER 71 0.0023
928 INTENTIONAL OVERDOSE 145 0.0023
929 EXPOSURE VIA SKIN CONTACT 57 0.0022
930 NEEDLE ISSUE 63 0.0022
931 SEDATION 56 0.0021
932 ACCIDENTAL OVERDOSE 78 0.0021
933 MALIGNANT NEOPLASM PROGRESSION 217 0.0021
934 HEPATIC FUNCTION ABNORMAL 79 0.0021
935 CONVULSION 121 0.0021
936 DEVICE BREAKAGE 84 0.0021
937 INJECTION SITE SWELLING 158 0.0021
938 INJECTION SITE URTICARIA 50 0.0020
939 GLYCOSYLATED HAEMOGLOBIN INCREASED 51 0.0020
940 ANAPHYLACTIC SHOCK 52 0.0020
941 ABNORMAL BEHAVIOUR 78 0.0020
942 RESPIRATORY ARREST 54 0.0020
943 AGGRESSION 98 0.0020
944 MENSTRUATION IRREGULAR 52 0.0019
945 INJECTION SITE PRURITUS 128 0.0019
946 APPLICATION SITE ERYTHEMA 50 0.0019
947 MYOCARDIAL INFARCTION 326 0.0019
948 DEMENTIA 52 0.0019
949 COMPLETED SUICIDE 155 0.0019
950 NEOPLASM PROGRESSION 64 0.0018
951 FOETAL EXPOSURE DURING PREGNANCY 149 0.0018
952 DEVICE ISSUE 164 0.0018
953 ANGER 61 0.0018
954 CEREBROVASCULAR ACCIDENT 304 0.0018
955 DEATH 1543 0.0018
956 MULTIPLE SCLEROSIS 85 0.0018
957 INJECTION SITE BRUISING 141 0.0018
958 WITHDRAWAL SYNDROME 74 0.0018
959 PRODUCT SUBSTITUTION ISSUE 99 0.0017
960 INJECTION SITE REACTION 115 0.0017
961 OVERDOSE 359 0.0017
962 PRODUCT QUALITY ISSUE 226 0.0017
963 DRUG ADMINISTRATION ERROR 51 0.0017
964 LUNG NEOPLASM MALIGNANT 68 0.0017
965 INJECTION SITE ERYTHEMA 204 0.0016
966 INJECTION SITE PAIN 501 0.0016
967 INJECTION SITE MASS 60 0.0016
968 NO ADVERSE EVENT 288 0.0016
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 322 0.0016
970 INCORRECT DOSE ADMINISTERED 362 0.0016
971 BLOOD GLUCOSE INCREASED 298 0.0016
972 INJECTION SITE RASH 48 0.0016
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 110 0.0015
974 DRUG DOSE OMISSION 253 0.0015
975 BLOOD GLUCOSE DECREASED 71 0.0015
976 NEOPLASM MALIGNANT 97 0.0015
977 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
978 PRODUCT STORAGE ERROR 120 0.0014
979 CEREBRAL HAEMORRHAGE 49 0.0014
980 DRUG ABUSE 112 0.0013
981 DRUG EFFECT DECREASED 69 0.0013
982 EXTRA DOSE ADMINISTERED 49 0.0012
983 DEVICE MALFUNCTION 84 0.0012
984 MULTIPLE SCLEROSIS RELAPSE 80 0.0012
985 ACCIDENTAL EXPOSURE TO PRODUCT 114 0.0011
986 INJECTION SITE HAEMORRHAGE 85 0.0011
987 COMA 50 0.0010
988 DRUG WITHDRAWAL SYNDROME 87 0.0010
989 DRUG DEPENDENCE 149 0.0009
990 DEVICE DIFFICULT TO USE 51 0.0008
991 BREAST CANCER 59 0.0006